Scientists said the drug trial of the treatment for melanoma could be the beginning of a transformation in care.

Moderna shares surged about 150% after Moderna and Merck reported positive Phase 3 results for a personalized mRNA treatment ...

The study also met a secondary goal of preventing cancer from spreading to different parts of the body.

The companies said their vaccine helped prevent the return and spread of melanoma in a trial that involved more than 1,000 ...

A new vaccine is changing how doctors treat certain skin cancer patients, according to doctors in the ArkLaTex.

The experimental mRNA vaccine successfully cleared phase 3 clinical trials, the last step necessary before it can be approved ...

Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug ...

Just a year after RFK Jr. cut half a billion of funding for the technology, mRNA vaccines are promising individualized cancer ...

Moderna and Merck said an experimental cancer vaccine paired with Keytruda helped prevent the recurrence of melanoma in a Phase 3 trial. In 2019, a friend noticed a suspicious mole on Angela Evatt's ...

Each patient's vaccine is built from an analysis of the mutations found in that patient's own tumour, CNN reported, rather ...

Your resource for the hottest moving stocks and news. We cover all sectors and markets giving everyday investors access to ...